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1. Introduction 
Sequence studies of either normal pooled material 
[ 1,2] or antibodies of limited heterogeneity [3,4] are 
in general agreement as to the multiple differences 
found between the three characterized allotypes (al, 
a2 and a3) of the a locus. 
The present report describes the partial amino acid 
sequence of a heavy chain of allotype al derived from 
a homogeneous antibody (designated Ab 120) directed 
against the carbohydrate of the cell wall of Micrococcus 
lysodeikticus. The sequence for residues 14- 16 is 
different from that reported earlier [l] for IgG Aal, 
but agrees with that reported by Johnstone and Mole 
(manuscript in preparation). 
2. Materials and methods 
Antibodies against M. lysodeikticus were induced 
in rabbits as described earlier [S] . They were charac- 
terized by cellulose acetate electrophoresis, precipitin 
reaction and polyacrylamide gel electrophoresis as 
reported [5]. 
Antibody 120 was isolated from a single bleeding 
and purified from the serum by DEAB cellulose ion 
exchange chromatography, using a 5 mM sodium 
phosphate buffer, pH 7.2, as eluent. 
Heavy and light chains were separated by gel 
filtration on Sephadex G 100, in 1 N acetic acid, 
after mild reduction (0.5 M Tris-HCl, pH 8.2, 0.1 M 
2-mercaptoethanol, 1 h at 37°C) and alkylation (0.12 
M iodoacetic acid, 30 min at 0°C). 
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Cyanogen bromide (CNBr) cleavage of the heavy 
chain was performed in 70% formic acid for 24 h at 
4”C, using a 1:5 weight ratio of protein to CNBr. The 
N-terminal half of the heavy chain (fragment C-l) from 
the CNBr digest of the heavy chain, and of the N- 
terminal 33 residue peptide from fragment C-l after 
complete reduction and alkylation with iodo-2-[ 14C] 
acetic acid, were isolated by gel filtration on G-100 in 
6 M urea, 1 N acetic acid, and on G-100 in 1 M NH40H 
respectively. The tryptic digestion of the 33 residue 
peptide was done using an enzyme:peptide ratio of 
1 :lOO (w/w) in 1% ammonium bicarbonate pH 8.0 
at 37°C for a period of 4 h. 
Sequence analysis was performed with a Beckman 
890 C sequenator using the DMAA program [6]. 
Identifications of the phenylthiohydantoin derivatives 
were by gas-liquid chromatography [7], thin-layer 
chromatography [8] and amino acid analysis on a 
Durrum 500 D analyser, after back hydrolysis in HI 
at 150°C for 20 h. 
3. Results 
The complete sequence of the light chain of 
antibody 120 was determined [9,10] and details will 
be reported elsewhere. 
The PCA (pyrrolidone carboxylic acid)-blocked 
N-terminal half of heavy chain Ab 120 (fragment C-l) 
was subjected to 16 automated Edman degradations 
(fig.1). The homology on comparison with known 
sequences from rabbit H chains [2,11 ,121 suggested 
that fragment C-l of H chain 120 was cleaved between 
residues 33 and 34. After complete reduction and 
alkylation, the blocked N-terminal fragment 1 to 33 
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‘was separated from the larger one, residue 34 to 256, 
by gel fntration. The N-terminal 33 residue peptide 
of the H-chain was isolated in 65% yield and subjected 
to tryptic digestion. The whole digest was directly 
analyzed by automated egradation. The sequence of 
residue 1 O-32 was established. Residues 1 to 9 and 
33, identified by amino acid analysis of the separated 
peptides, were placed by homology. 
4. Discussion 
The comparison of the amino acid sequence of the 
N-terminal 49 residues of H chain of allotypes al, a2 
and a3 is shown in fig.2. Several Aal sequences are 
included in the comparison because of variations in 
residue 14, 15 and 16. Results by lohnstone and 
Mole (manuscript in preparation) suggests hat the 
1 10 20 
PCA (Ser Val Glu Glu Ser Gly Gly Arg) Leu Val Thr Pro Gly Thr Pro Leu Thr Leu Thr Cys Thr Val Ser Gly 
t 
Trypsin 
30 40 
Phe Ser Leu Ser Ser Tyr Asp Met Ala Trp Val Arg Gin Ala Pro Gly Lys Gly Leu Glu Trp Be Gly He 
t 
CNBr 
Fig.1. Sequence of fragment 1 to 49 of heavy chain 120. The placing of the peptides is by homology. 
10 20 30 40 
al 120 M.L. O-(SVEESGG)KLVTPG~~LTLTCTVSGFSLSSYDMAWVRQAPGKGLEWIGI 
al BS5 S 3 0- SCVE)ESGGRLVTPTPGLTLTCTVSGFSLSSYDMGWVRQAPGKGLEWIGI 
al Pool O-SVEESGGRLVTPGTPLTLTCTVSGFSLSSYAMGWVRQAPGKGLEWIGI 
L A D?S Y F 
Y 
a2 K25 S 3 O-SVKESEGGLFKPTDTLTLTCTVSGFSLSGYDMSWVRQAPGKGLEWIGV 
a2 2690C O-SVKESEGGLFKPTNTLTLTCTVSGIDLSSYGVSWVRQAPGKGLEWIGI 
a3 Pool OESLEESGGDLVKPGASLTLTCTASGFNGSSYYM 
Q v ? ? V A F ? 
Fig.2. Data for al and a3 normal pooled H chains are from Wilkinson [l], Mole et al. [2] and Johnstone and Mole (manuscript 
in preparation). Data the sequence of anti-(type III pneumococci) H chain BS-5 is from Jaton and Braun 1211 and that of anti- 
(group C streptococcal carbohydrate) H chain R-2690 is from Fleischman [ 31. 
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sequence Gly-Thr-Pro which we obtain in Ab 120 
heavy chain is also found in normal pooled IgG and 
IgA preparations of allotype al. Previous tudies using 
normal pooled IgG concluded in the sequence Thr- 
Pro-Gly by indirect methods [1 ] . 
The only heavy chain (BS-5) which had the 
sequence Thr-Pro-Gly [ 121 instead of Gly-Thr-Pro 
must therefore presumably belong to a rare variant of 
Aal chains not detected in normal pooled IgG or IgA 
of this allotype. 
Previous equence studies [1 l] have indicated that 
homogeneous antibodies may not necessarily contain 
all the allotypically associated residues of an a locus 
allotype. Serological analyses have suggested the 
existence of allotypic variants [13-l 61. The complex 
polymorphism of the a and b genes would lend 
support o the idea that the various allotypic forms 
of the a and b locus do not correspond to simple 
alleles but rather eveal the existence of a regulatory 
control over coexisting enes [171. 
It was on the N-terminal 33 residue portion of 
fragment C-l represented in fig.1 that Wilkinson 
initially correlated the a locus allotype and the al and 
a3 specificities. This study was later completed by 
Fleischman for the a2 specificity (see flg.2). When 
using what we believe to be the definitive al sequence, 
with Gly-Thr-Pro instead of Thr-Pro-Gly, the 
allotype-related sequence correlates may be summa- 
rized as: 
the residues in positions 9, 15 and 16 are specific 
for each allotypic form; 
the residues in positions 4,7, 11, 12, 14 and 28 
are associated with two of the three forms; 
Aal and Aa sequences are more homologous to 
each other than to Aa2. 
This confirms the serological observations by Brezin 
and Cazenave [ 151. Since the new specificity al 00 
[ 181 is closer to allotype a3 than to any other 
specificity, it may be expected that the sequence will 
confirm this greater homology. 
The parts of the variable regions of the antibody 
heavy chains represented in fig.2 do not reveal 
extensive differences, even in the section 30 to 34 
which in human myeloma chains corresponds to the 
first hypervariable r gion of the heavy chain, possibly 
involved in antigen binding. Section 35 to 45 is 
conserved in all the chains, and probably corresponds 
to the spatial configuration characterized by X-ray 
diffraction studies on human antibody or myeloma 
protein fragments [19,20] : two P-pleated sheets 
joined by a bend at Pro-40 and Gly-41. Studies of the 
second and third hypervariable r gions will usefully 
complete this initial comparison. 
A more precise definition of structure-function 
relationship clearly makes necessary the determination 
of a much larger number of antibody heavy chain 
sequences of similar anti-carbohydrate specificity and 
of chains from homogeneous antibodies directed 
against non-carbohydrate antigens. 
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